Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Gastroparesis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
Gastroparesis - Epidemiology Forecast to 2030 delivers an in-depth understanding of the disease, historical and forecasted Gastroparesis epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Study Period: 2017-2030
Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalence of Gastroparesis, Gender-specific Prevalence of Gastroparesis, Severity-specific Prevalence of Gastroparesis, Type-specific Prevalence of Gastroparesis and Total Diagnosed Prevalent Population of Gastroparesis a scenario of Gastroparesis in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom) and Japan from 2017 to 2030.
Detailed Epidemiology Segmentation
Scope of the Report
Key Questions Answered
Key Topics Covered
1 Key Insights
2 Gastroparesis: Market Overview at a Glance
2.1. Total Market Share (%) Distribution of Gastroparesis in 2017
2.2. Total Market Share (%) Distribution of Gastroparesis in 2030
3 Executive Summary
4 SWOT Analysis
5 Gastroparesis: Disease Background and Overview
5.1 Introduction
5.2 Types of Gastroparesis: Based on Causes
5.2.1 Idiopathic Gastroparesis (IG)
5.2.2 Diabetic Gastroparesis (DGp)
5.2.3 Iatrogenic and Postsurgical Gastroparesis
5.3 Clinical Signs and Symptoms
5.4 Mechanisms or pathophysiology of gastroparesis
5.5 Diagnosis of Gastroparesis
6 Recognized Establishments
7 Epidemiology and Patient Population
7.1 Key Findings
7.2 Epidemiology Methodology
7.3 Total Prevalence of Gastroparesis in the 7MM
7.4 Type-specific Prevalence of Gastroparesis in the 7MM
7.5 Gender-specific Prevalence of Gastroparesis in the 7MM
7.6 Severity-specific Prevalence of Gastroparesis in the 7MM
7.7 Total Diagnosed Prevalent Population of Gastroparesis in the 7MM
8 United States Epidemiology
8.1 Assumptions and Rationale
8.2 Total Prevalence of Gastroparesis in the United States
8.3 Type-specific Prevalence of Gastroparesis in the United States
8.4 Gender-specific Prevalence of Gastroparesis in the United States
8.5 Severity-specific Prevalence of Gastroparesis in the United States
8.6 Total Diagnosed Prevalence of Gastroparesis in the United States
9 EU5 Epidemiology
9.1 Germany Epidemiology
9.2 France Epidemiology
9.3 Italy Epidemiology
9.4 Spain Epidemiology
9.5 United Kingdom Epidemiology
10 Japan
10.1 Assumptions and Rationale
10.2 Total Prevalence of Gastroparesis in Japan
10.3 Type-specific Prevalence of Gastroparesis in Japan
10.4 Gender-specific Prevalence of Gastroparesis in Japan
10.5 Severity-specific Prevalence of Gastroparesis in Japan
10.6 Total Diagnosed Prevalence of Gastroparesis in Japan
For more information about this report visit https://www.researchandmarkets.com/r/atgajs
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.